WSCC yields 181.82% · PFE yields 6.20%● Live data
📍 WSCC pulled ahead of the other in Year 1
Combined, WSCC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WSCC + PFE for your $10,000?
Waterside Capital Corporation is no longer investing. It is a venture capital, and private equity firm specializing in investments in mezzanine debt for growth expansion; management buyouts; recapitalizations; leveraged buyouts; acquisitions; and working capital. The firm also provides bridge financing. It seeks to invest in small private and public companies and small middle market companies. The firm does not invest in start-ups, turnaround situations, oil or gas exploration, real estate development, and direct lending businesses. The firm prefers to invest in companies based in the Mid-Atlantic region and also invests in small businesses based in Richmond, Hampton Roads, Virginia, Washington D.C., North Carolina, and Maryland. The firm prefers to provide, with a more than five year term with flexible amortization, between $500,000 and $3 million as subordinate loans and between $1 million and $3 million as senior debt financing. It prefers to invest in companies that have annual revenues greater than $5 million. The firm co-invests in case of large investments and prefers to structure its investments as debt with attached warrants on common stock or as senior debts. The firm prefers equity participation when it provides subordinate loans and a collateral of assets while providing senior debt financing. Westside Capital Corporation was founded in 1993 and is based in Virginia Beach, Virginia.
Full WSCC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.